Group beats €100m target and intends to invest the bulk of the fund in Europe and US

Figures from Mergermarket show the value of transactions jumped 370% in 2018

Seen and heard: PwC to review children’s hospital costs, ESB may offload Dublin depot

Inflazome in one of the largest European biotech fundraisings this year as it targets range of serious inflammatory diseases

After several false starts, way is clear for John Thero to take Vascepa cholesterol drug to market

Irish healthcare venture capital group Fountain among backers of HRT alternative

Group completes back pain neurostimulator implants in all 204 patients enrolled in test for device

Galway medical device firm developing rhinitis cure device for use in doctors’ offices

Inflection Biosciences seeking phase I testing for new therapy targeting aggressive cancer

Fountain Healthcare participates in €17m funding round for Syndesi Therapeutics

Irish medtech start-up seeking to commercialise non-invasive device for condition

Dublin-listed medical devices firm recently made its first commercial sale in Germany

Sale of Neuravi is largest deal for a venture-backed medtech in Europe since 2009

Iseq-listed medical device firm targets commercial growth and completion of US clinical trials

Dublin-listed firm pushes ahead with plans to commercialise back pain treatment

Company’s flagship product ReActiv8 won European approval earlier this year

Chrono Therapeutics developing device to deliver nicotine through skin in timed doses

Start-up’s technology allows surgeons to finish heart surgery without leaving stitches

Operating expenses also decline while R&D and clinical and regulatory costs rise

Firm developing products to treat postoperative pain and diabetic foot infections